BIO-REFERENCE LABS INC-NEW-
BRLI
BRLI was delisted on the 19th of August, 2015.
0 hedge funds and large institutions have $0 invested in BIO-REFERENCE LABS INC-NEW- in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $193K → $0 (-$193K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Shell Asset Management
The Hague,
Netherlands
|
-$193K |
BRLI Hedge Fund Activity: Q4 2015 in Review
0 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in BIO-REFERENCE LABS INC-NEW- (BRLI) for Q4 2015, worth a combined $0 — down 100% from $193K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BRLI and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Shell Asset Management, exiting entirely with an estimated $193K sold.
- 0 institutional investors held BIO-REFERENCE LABS INC-NEW- (BRLI) as of Q4 2015, down from 1 in Q3 2015.
- Funds reported $0 of BIO-REFERENCE LABS INC-NEW- stock for Q4 2015, down 100% quarter-over-quarter.
- 0 funds opened new BIO-REFERENCE LABS INC-NEW- positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest BIO-REFERENCE LABS INC-NEW- seller in Q4 2015 was Shell Asset Management, an estimated $193K sold.
Based on aggregated 13F filings for Q4 2015.